MedTrace Logo

Study to Prevent Negative Thoughts of Life

NCT00862732 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2009-03-17

No results posted yet for this study

Summary

The purpose of the study is to test whether cognitive behaviour therapy (CBT) offered by trained therapists, to people with current active suicidal ideations, is efficacious as a secondary prevention strategy in Sri Lanka, when compared with treatment as usual provided by Medical Officers (Mental Health; MO (MH)) of government hospitals

Conditions

  • Active Suicidal Ideations

Interventions

BEHAVIORAL

Cognitive behavioural therapy

Will receive a series of sessions of cognitive behaviour therapy. Delivery of CBT will be by three therapists; PI and two other Medical Officers. Each session will last for 30- 45 minutes and they will be delivered at the participant's residence (or at an alternative place of participant's choice) at two weeks intervals. They will be followed-up for three months from the cessation of CBT sessions.

OTHER

Treatment as usual

Will be referred to the MO(MH). They also will be followed-up for an equal length of time period as of the participants in the intervention group.

Sponsors & Collaborators

  • Institute of Psychiatry, London

    collaborator OTHER

  • Institute for Research & Development Sri Lanka

    lead OTHER

Principal Investigators

  • Sudath Samaraweera, MBBS MSc MD · Institute for Research & Development Sri Lanka

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • Sri Lanka

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00862732 on ClinicalTrials.gov